A retrospective population-based cohort study has shown that outcomes were worse for patients with neuropathic pain who received long-term opioid treatment than for those who received short-term opioid treatment. The finding highlights a need for improved pain education for non-specialists and for more-effective therapies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Arner, S. & Meyerson, B. A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33, 11–23 (1988).
Watson, C. P. & Babul, N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50, 1837–1841 (1998).
Sindrup, S. H. et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 83, 85–90 (1999).
Finnerup, N. B. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 14, 162–173 (2015).
Hoffman, E. M. et al. Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy. JAMA Neurol. http://dx.doi.org/10.1001/jamaneurol.2017.0486 (2017).
Kolodny, A. et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu. Rev. Public Health 36, 559–574 (2015).
Häuser, W. et al. The opioid epidemic and the long-term opioid therapy for chronic noncancer pain revisited: a transatlantic perspective. Pain Manag. 6, 249–263 (2016).
Morley, K. I. et al. Polysubstance use and misuse or abuse of prescription opioid analgesics: a multi-level analysis of international data. Pain 158, 1138–1144 (2017).
Hannon, B. et al. Provision of palliative care in low- and middle-income countries: overcoming obstacles for effective treatment delivery. J. Clin. Oncol. 34, 62–68 (2016).
Dowell, D., Haegerich, T. M. & Chou, R. CDC guideline for prescribing opioids for chronic pain — United States, 2016. JAMA 315, 1624–1645 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author has served as a consultant, given educational talks and has been involved in clinical trials for Air Liquide, Astellas, Grünenthal and Pfizer.
Rights and permissions
About this article
Cite this article
Sommer, C. Long-term opioid therapy in neuropathy: benefit or harm?. Nat Rev Neurol 13, 516–517 (2017). https://doi.org/10.1038/nrneurol.2017.101
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2017.101
This article is cited by
-
Blocking of Caveolin-1 Attenuates Morphine-Induced Inflammation, Hyperalgesia, and Analgesic Tolerance via Inhibiting NLRP3 Inflammasome and ERK/c-JUN Pathway
Journal of Molecular Neuroscience (2022)
-
Chronic morphine-mediated upregulation of high mobility group box 1 in the spinal cord contributes to analgesic tolerance and hyperalgesia in rats
Neurotherapeutics (2020)
